Summary
The FDA approved a new generic version of the abortion pill mifepristone, sparking criticism from anti-abortion groups and some politicians. The pill can be used to end pregnancies up to 10 weeks and is produced by Evita Solutions. The approval process for generic drugs is typically routine, and the new pill will be available next year.
Key Facts
- The FDA approved a generic version of the abortion pill mifepristone from Evita Solutions.
- Mifepristone is used to end pregnancies up to 10 weeks.
- The approval has faced criticism from anti-abortion groups and some politicians.
- The FDA states it has limited discretion in approving generic drugs.
- Mifepristone was first approved by the FDA in 2000, with the first generic version approved in 2019.
- In 2021, rules were eased to allow online prescribing and mail delivery of the drug.
- The application process for this generic took four years.
- The new generic version is expected to launch in January next year.
